ImmunityBio Inc. Common Stock vs Liberty Energy Inc. Class A common stock — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while Liberty Energy Inc. Class A common stock trades at $18.82 (market cap $3.17B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 3.3× Liberty Energy Inc. Class A common stock's market cap, and Liberty Energy Inc. Class A common stock pays a 1.85% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Liberty Energy Inc. Class A common stock for 0 Days on average.
| IBRX | LBRT | |
|---|---|---|
Market Cap | $10.33B | $3.17B |
Volume | 11,745,198 | 2,938,382 |
Sector | Health | Energy |
52-Week High | $11.55 | $33.93 |
52-Week Low | $1.98 | $11.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $4.23B |
Dividend Yield | — | 1.85% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Liberty Energy provides completion services and technologies for onshore oil, natural gas, and geothermal producers in North America. It also offers distributed power and energy-storage solutions through Liberty Power Innovations.
Read more on LBRT →